Clinical Trials on Tuberculosis, Multidrug-Resistant
Total 0 results
Nothing found
Sponsors and Collaborators
- Hospitales Universitarios Virgen del Rocío
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- AlpinARC
- Daniela Pacella - University of Naples Federico II, Naples
- Glasgow Western Infirmary
- ECMC
- Etan Orgel
- Sahachat Aueyingsak
- Bassam Abdulkarim
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Dr Philippe METELLUS
- Centro Universitário Franciscano
- Åke Wibergs Stiftelse
- National Institute of Cardiovascular Diseases, Bangladesh
- Sublimity Therapeutics Holdco Limited
- the people hospital of Linzhi
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- View Full List
Medical Conditions
- Progression to PD-1 Antibody
- Eosinophil Blood Count
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Genetic Risk Factor
- Legal History
- Patients With Leptomeningeal Disease
- Pancreaticoduodenectomy
- Interviews
- Panniculectomy
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Initiation of Depo-Provera (DMPA)
- Degenerative Spondylolisthesis G1
- Ability to Swim 100m Independent Freestyle
- Hyperprolinemia
- Transitional Cell Carcinoma of Renal Pelvis
- Orthopaedic Disorders
- Value-Based Health Insurance
- View Full List
Drug Interventions
- Epirubicin hydrochloride
- Gefitinib
- Erythropoietin
- ASP8062
- HBM4003 and Triprilimab
- Injectable Insulin
- 5-Fluoro-uracil
- Prasugrel
- 6% hetastarch
- UFUR and Iressa
- Cefuroxime 750mg oral
- Nimotuzumab
- Mepivacaine
- IV rtPA (intravenous recombinant plasminogen activator)
- Omeprazole 20mg
- Metoclopramide + dexamethasone
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Antibiotic treatment
- Paliperidone palmitate
- 0% N2O
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Benin
- Contract Research Organizations in Brazil
- Contract Research Organizations in Burundi
- Contract Research Organizations in France
- Contract Research Organizations in Ireland
- Contract Research Organizations in Italy
- Contract Research Organizations in Latvia
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Singapore
- Contract Research Organizations in Slovakia
- Contract Research Organizations in South Africa
- CRO list by country